TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32853646

Group type: EXPERIMENTAL
Intervention: Water pressure (WP) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DualKnife J
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Late treatment phase
Number of subjects: 0
Study: 32075185

Group type: EXPERIMENTAL
Intervention: Mixed supervised/home‐based exercise program for six months
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group without exercise
Number of subjects: 6
Study: 34749577

Group type: EXPERIMENTAL
Intervention: Power Training (PT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Plyometric Jump Training (PJT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 33
Study: 33159256

Group type: EXPERIMENTAL
Intervention: High-dose mizoribine (MZR) pulse therapy combined with steroid treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional treatment of steroid combined with cyclophosphamide (CPM)
Number of subjects: 60
Study: 32853755

Group type: EXPERIMENTAL
Intervention: Simulation-based training followed by neurofeedback sessions
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (not receiving simulation-based training and neurofeedback)
Number of subjects: 32
Study: 35882875

Group type: EXPERIMENTAL
Intervention: Visible BIS group (depth of anaesthesia sustained between 40 and 60)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Hidden BIS group (depth of anaesthesia guided by hemodynamic parameters and Minimum Alveolar Concentration)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Visible BIS group
Number of subjects: 69

Group type: COMPARATOR
Intervention: Hidden BIS group
Number of subjects: 69
Study: 33763699

Group type: EXPERIMENTAL
Intervention: Ixazomib 4 mg plus lenalidomide and dexamethasone (Rd)
Number of subjects: 705

Group type: COMPARATOR
Intervention: Placebo plus lenalidomide and dexamethasone (Rd)
Number of subjects: 705
Study: 32862697

Group type: EXPERIMENTAL
Intervention: History of hypertension
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Every 10 mmHg increase in SBP >125 mmHg
Number of subjects: 13885

Group type: EXPERIMENTAL
Intervention: Every decrease in 10 mmHg SBP ≤125 mmHg
Number of subjects: 13885
Study: 36106858

Group type: EXPERIMENTAL
Intervention: Melatonin 10 mg
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 34106753

Group type: EXPERIMENTAL
Intervention: Reduced-intensity hematopoietic cell transplantation (HCT) in the Donor arm
Number of subjects: 384

Group type: COMPARATOR
Intervention: Best supportive care or hypomethylating therapy in the No-Donor arm
Number of subjects: 384
Study: 33508252

Group type: EXPERIMENTAL
Intervention: 4-item Person-Centered Contraceptive Counseling scale (PCCC)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 11-item Interpersonal Quality of Family Planning (IQFP) scale
Number of subjects: 33
Study: 32448171

Group type: EXPERIMENTAL
Intervention: Metastasis-directed therapy to all visible progressive lesions
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: PSMA PET‐CT imaging
Number of subjects: 18
Study: 36233540

Group type: EXPERIMENTAL
Intervention: King Vision™ Paediatric aBlade™ video laryngoscope (KVL)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Direct Laryngoscopy (DL)
Number of subjects: 11
Study: 33861742

Group type: EXPERIMENTAL
Intervention: Training of traditional and religious leaders in intervention LGAs
Number of subjects: 2598

Group type: COMPARATOR
Intervention: Control group (no training of traditional and religious leaders)
Number of subjects: 2598
Study: 35604530

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Atezolizumab
Number of subjects: 2
Study: 32682484

Group type: EXPERIMENTAL
Intervention: Carfilzomib, dexamethasone, and daratumumab (KdD)
Number of subjects: 466

Group type: COMPARATOR
Intervention: Carfilzomib and dexamethasone (Kd)
Number of subjects: 466
Study: 34183429

Group type: EXPERIMENTAL
Intervention: iGlarLixi (once-daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: BIAsp 30 (twice-daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0
Study: 32408108

Group type: EXPERIMENTAL
Intervention: Bowel protocols using senna (81.0%) and bisacodyl (75.6%) among others.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Bowel protocols activated by nurses (62.8%) based on initiation criteria.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Laxative escalation criteria.
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Discontinuation criteria for bowel protocols.
Number of subjects: 44
Study: 36152128

Group type: EXPERIMENTAL
Intervention: Paternal exposure to arsenic
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Co-exposure to arsenic and mercury
Number of subjects: 352
Study: 32352642

Group type: EXPERIMENTAL
Intervention: Plasma retinol levels <58.3 μg/dL
Number of subjects: 1234

Group type: EXPERIMENTAL
Intervention: Plasma retinol levels ≥58.3 μg/dL
Number of subjects: 1234

Group type: EXPERIMENTAL
Intervention: Higher time-averaged SBP (≥140 mm Hg) in participants with plasma retinol <58.3 μg/dL
Number of subjects: 1234

Group type: EXPERIMENTAL
Intervention: Higher vitamin E levels (≥11.5 μg/mL) in participants with plasma retinol <58.3 μg/dL
Number of subjects: 1234
Study: 35880280

Group type: COMPARATOR
Intervention: Warm needling
Number of subjects: 90

Group type: COMPARATOR
Intervention: Balance acupotomy
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Combined treatment (balance acupotomy + warm needling)
Number of subjects: 90
Study: 34000503

Group type: EXPERIMENTAL
Intervention: Air cleaner devices (recirculating and filtering air)
Number of subjects: 2123

Group type: COMPARATOR
Intervention: Normal air (control group)
Number of subjects: 2123
Study: 32230987

Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg twice daily in Week 1) followed by Inulin (4 g twice daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo (twice daily in Week 1) followed by Inulin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo-Placebo
Number of subjects: 60
Study: 33039185

Group type: EXPERIMENTAL
Intervention: Complete dentures with palatal rugae
Number of subjects: 50

Group type: COMPARATOR
Intervention: Complete dentures with polished palate
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: OHIP-EDENT total scores with palatal rugae
Number of subjects: 50
Study: 32931308

Group type: EXPERIMENTAL
Intervention: Dextrose prolotherapy (DPT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA)
Number of subjects: 32
Study: 34607479

Group type: EXPERIMENTAL
Intervention: GDM group (74 patients)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Normal pregnant group (31 women)
Number of subjects: 105
Study: 33788480

Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture, moxibustion, Chinese herbal medicine, and western medication)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Western medication group (clomiphene citrate, chorionic gonadotrophin, and aspirin)
Number of subjects: 60
Study: 32780258

Group type: EXPERIMENTAL
Intervention: Probiotic Group (PG) received Lactobacillus acidophilus and Bifidobacterium lactis (5 billion CFU/strain) for 90 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control Group (CG) received tablets with starch
Number of subjects: 73
Study: 33455938

Group type: EXPERIMENTAL
Intervention: Extracorporeal cytokine adsorption using the CytoSorb device
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no cytokine adsorption)
Number of subjects: 80
Study: 32298270

Group type: EXPERIMENTAL
Intervention: Sensory Attention Focused Exercise (SAFEx), n = 18
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham Exercise control (external focus of attention), n = 17
Number of subjects: 35
Study: 36235570

Group type: EXPERIMENTAL
Intervention: BCAA (8 g)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Soy protein (7.5 g)
Number of subjects: 36
Study: 32822692

Group type: EXPERIMENTAL
Intervention: Early or late prenatal vitamin D sufficiency (25(OH)D level ≥ 30 ng/mL) among mothers with asthma
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Early and late prenatal vitamin D sufficiency (25(OH)D level ≥ 30 ng/mL) among mothers with asthma
Number of subjects: 806

Group type: EXPERIMENTAL
Intervention: Early or late prenatal vitamin D sufficiency (25(OH)D level ≥ 30 ng/mL)
Number of subjects: 806
Study: 35811277

Group type: EXPERIMENTAL
Intervention: HFOV combined with prone position (HFOV-PP)
Number of subjects: 65

Group type: COMPARATOR
Intervention: HFOV combined with supine position (HFOV-SP)
Number of subjects: 65
Study: 34100099

Group type: EXPERIMENTAL
Intervention: Balloon guide catheter (BGC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional guide catheters
Number of subjects: 0
Study: 32338067

Group type: EXPERIMENTAL
Intervention: Glycine max (L.) Merr isoflavone 4% vaginal gel
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison between isoflavone and placebo groups
Number of subjects: 22
Study: 34518253

Group type: EXPERIMENTAL
Intervention: selfBACK app adjunct to usual care
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: e-Help website adjunct to usual care
Number of subjects: 279

Group type: COMPARATOR
Intervention: usual care only
Number of subjects: 279
Study: 32160348

Group type: EXPERIMENTAL
Intervention: Weight maintenance phase after low-energy diet
Number of subjects: 1856

Group type: EXPERIMENTAL
Intervention: Demographic and sociocognitive factors
Number of subjects: 1856
Study: 35641010

Group type: EXPERIMENTAL
Intervention: Testosterone gel
Number of subjects: 986

Group type: COMPARATOR
Intervention: Standard recommended treatment regimen of chronic stable heart failure
Number of subjects: 986
Study: 32517739

Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Crossover cohort (HA to CRFA)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Hyaluronic acid (HA) injection
Number of subjects: 177
Study: 36083159

Group type: EXPERIMENTAL
Intervention: High-energy visible (HEV) light-filtering contact lens
Number of subjects: 61

Group type: COMPARATOR
Intervention: Clear comparison contact lens
Number of subjects: 61
Study: 32298143

Group type: EXPERIMENTAL
Intervention: Peer concussion-education program (PCEP)
Number of subjects: 1614
Study: 35791797

Group type: EXPERIMENTAL
Intervention: Tegoprazan (50 mg) based triple therapy (TPZ)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Lansoprazole (30 mg) based triple therapy (LPZ)
Number of subjects: 350
Study: 34374027

Group type: EXPERIMENTAL
Intervention: SHR0302 4 mg once daily
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: SHR0302 8 mg once daily
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 32712654

Group type: EXPERIMENTAL
Intervention: Spot-stent grafting (SSG)
Number of subjects: 22
Study: 36403953

Group type: EXPERIMENTAL
Intervention: Barbed sutures
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: VICRYL
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ethibond
Number of subjects: 120

Group type: COMPARATOR
Intervention: Barbed sutures, VICRYL, Ethibond
Number of subjects: 120
Study: 33054769

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients
Number of subjects: 474268

Group type: COMPARATOR
Intervention: Control group (age-, sex-, and diagnosis date-matched)
Number of subjects: 474268

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients aged < 45 years
Number of subjects: 474268

Group type: EXPERIMENTAL
Intervention: Some anti-diabetic medications
Number of subjects: 474268
Study: 34062178

Group type: EXPERIMENTAL
Intervention: Story tweets
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard tweets
Number of subjects: 54
Study: 32460736

Group type: EXPERIMENTAL
Intervention: Home delivery assisted by non-skilled birth attendants
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Husband chooses the place of delivery
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Mothers' occupation
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Antenatal care (ANC) visit
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Decision making regarding delivery
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Use of traditional remedies
Number of subjects: 451
Study: 36752455

Group type: EXPERIMENTAL
Intervention: Hybrid ablation (HA)
Number of subjects: 41
Study: 32496397

Group type: EXPERIMENTAL
Intervention: Early inflammatory measures (cytokines, chemokines, growth factors)
Number of subjects: 62
Study: 35044810

Group type: EXPERIMENTAL
Intervention: Carboplatin
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 443

Group type: COMPARATOR
Intervention: Weekly paclitaxel (wP) followed by doxorubicin and cyclophosphamide
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Pathologic complete response (pCR)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Immune activation markers
Number of subjects: 443
Study: 33998026

Group type: EXPERIMENTAL
Intervention: Concern about the severity of HPAI
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Media and/or peer influence
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: High importance of practicing water-related biosecurity
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Past experiences with HPAI
Number of subjects: 600
Study: 33952200

Group type: EXPERIMENTAL
Intervention: Specific age recall BMI trajectories
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Decade recall BMI trajectories
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Combined models of specific age and decade recall BMI
Number of subjects: 249
Study: 33198652

Group type: EXPERIMENTAL
Intervention: nab‐PTX plus RAM
Number of subjects: 251

Group type: COMPARATOR
Intervention: PTX plus RAM
Number of subjects: 251
Study: 33136223

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 1982

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1982

Group type: EXPERIMENTAL
Intervention: Baseline walk distance ≤ 200 m
Number of subjects: 1982

Group type: EXPERIMENTAL
Intervention: Decline in walk distance over 6 months
Number of subjects: 1982
Study: 33977797

Group type: EXPERIMENTAL
Intervention: Acupuncture (group A)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control (group C)
Number of subjects: 70
Study: 33495262

Group type: EXPERIMENTAL
Intervention: Interventions for the prevention of musculoskeletal pain and common mental disorders
Number of subjects: 0
Study: 36050704

Group type: EXPERIMENTAL
Intervention: Ketorolac injection
Number of subjects: 64

Group type: COMPARATOR
Intervention: Triamcinolone injection
Number of subjects: 64
Study: 32694619

Group type: EXPERIMENTAL
Intervention: sHDCT/ASCT (salvage high-dose chemotherapy and autologous stem cell transplantation) with lenalidomide maintenance (10 mg/day) after 3 Rd reinduction cycles (lenalidomide 25 mg, day 1–21; dexamethasone 40 mg, day 1, 8, 15, and 22; 4-week cycles)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Continuous Rd (lenalidomide and dexamethasone)
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: sHDCT/ASCT
Number of subjects: 277

Group type: COMPARATOR
Intervention: Continuous Rd
Number of subjects: 277
Study: 35627863

Group type: EXPERIMENTAL
Intervention: Fair condition (cooperation) in the prisoner’s dilemma game
Number of subjects: 342

Group type: COMPARATOR
Intervention: Unfair condition (defection) in the prisoner’s dilemma game
Number of subjects: 342
Study: 34280509

Group type: EXPERIMENTAL
Intervention: Circuit resistance training (1–3 rounds, 11 exercises, 10–15 reps, 50%–60% of 1RM, 3 times per week for 12 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 34
Study: 35590451

Group type: EXPERIMENTAL
Intervention: Electronic job aid-supported nutrition counselling and practical demonstration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual practice (comparison arm)
Number of subjects: 0
Study: 34656026

Group type: EXPERIMENTAL
Intervention: NutriAct intervention group with supplementation of rapeseed oil and specifically designed foods, along with repetitive advice to implement a high-protein and high-polyunsaturated fatty acid dietary pattern.
Number of subjects: 502

Group type: COMPARATOR
Intervention: Usual care control group including dietary recommendations of the German Nutrition Society (DGE).
Number of subjects: 502
Study: 32985089

Group type: EXPERIMENTAL
Intervention: Continuous nursing based on wechat platform
Number of subjects: 95

Group type: COMPARATOR
Intervention: Routine continuous nursing
Number of subjects: 95
Study: 32750373

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program plus usual care
Number of subjects: 210

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 210
Study: 32571567

Group type: EXPERIMENTAL
Intervention: Uninterrupted (or minimally interrupted) direct oral anticoagulants (DOACs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuous vitamin K antagonists
Number of subjects: 0
Study: 32482433

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (TE) program in combination with the integrated neuromuscular inhibition technique (INIT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Therapeutic exercise (TE) program without the integrated neuromuscular inhibition technique (INIT)
Number of subjects: 40
Study: 35648736

Group type: EXPERIMENTAL
Intervention: Answer boxes at the top of search results
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: Vocal replies from an intelligent personal assistant (IPA)
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: Multiple questions posed to an IPA with biased answers
Number of subjects: 1736

Group type: EXPERIMENTAL
Intervention: Simple masking procedures
Number of subjects: 1736
Study: 34126221

Group type: EXPERIMENTAL
Intervention: All-suture anchor (ASA) 2.6 mm
Number of subjects: 20

Group type: COMPARATOR
Intervention: Metallic anchor (MA) 3.5 mm
Number of subjects: 20
Study: 33168234

Group type: EXPERIMENTAL
Intervention: Optimized delayed-release and extended-release methylphenidate (DR/ER‐MPH)
Number of subjects: 0
Study: 33517904

Group type: EXPERIMENTAL
Intervention: Falls prevention exercise intervention (specific exercises not detailed)
Number of subjects: 23
Study: 34198290

Group type: EXPERIMENTAL
Intervention: Fr16 access size
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fr18 access size
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fr20 access size
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Fr22 access size
Number of subjects: 160
Study: 35013131

Group type: EXPERIMENTAL
Intervention: Lisdexamfetamine dimesylate (50 mg)
Number of subjects: 22
Study: 32731836

Group type: EXPERIMENTAL
Intervention: Uncemented tantalum metal tibial component
Number of subjects: 90

Group type: COMPARATOR
Intervention: Cemented tibial component
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Uncemented tibial component
Number of subjects: 90
Study: 35058090

Group type: EXPERIMENTAL
Intervention: Intraoperative injection of 10 ml (133 mg) liposomal bupivacaine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no local anesthetic)
Number of subjects: 0
Study: 33544448

Group type: EXPERIMENTAL
Intervention: Pumpkin seed oil (PSO)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Minoxidil 5% foam
Number of subjects: 60
Study: 33267706

Group type: EXPERIMENTAL
Intervention: Base-layer scrubs made of a cooling fabric
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional medical scrubs
Number of subjects: 10
Study: 32681303

Group type: EXPERIMENTAL
Intervention: Aerobic and resistance exercise intervention (supervised, moderate-vigorous, thrice weekly for 16 weeks)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study: 32703288

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)‐based depression prevention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Psycho-education (Control)
Number of subjects: 130
Study: 36432607

Group type: EXPERIMENTAL
Intervention: 8 mg·kg bw−1 of caffeine (CF8)
Number of subjects: 21
Study: 34536801

Group type: EXPERIMENTAL
Intervention: Autoclave aging
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Hydrothermal reactor aging
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control
Number of subjects: 126
Study: 34983750

Group type: EXPERIMENTAL
Intervention: Integrated neonatal care kit (iNCK)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current local standard of care
Number of subjects: 0
Study: 33497547

Group type: EXPERIMENTAL
Intervention: Naltrexone-bupropion
Number of subjects: 403

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 403
Study: 35460400

Group type: EXPERIMENTAL
Intervention: Estrogen valerate pretreatment (2 mg twice a day from Day 7 after ovulation to Day 2 of the next menstrual cycle)
Number of subjects: 552

Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 552

Group type: EXPERIMENTAL
Intervention: Estrogen valerate pretreatment
Number of subjects: 552

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 552
Study: 34663095

Group type: EXPERIMENTAL
Intervention: Concurrent partner treatment with oral metronidazole (400 mg) and 2% clindamycin cream applied topically to penile skin, both twice daily for 7 days.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Concurrent partner treatment
Number of subjects: 34
Study: 32250461

Group type: COMPARATOR
Intervention: Current use of antidepressants (overall)
Number of subjects: 24155

Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitors (SSRIs)
Number of subjects: 24155

Group type: COMPARATOR
Intervention: Trazodone
Number of subjects: 24155

Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 24155

Group type: COMPARATOR
Intervention: Other antidepressants
Number of subjects: 24155
Study: 34969175

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 8399

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 8399
Study: 34482211

Group type: EXPERIMENTAL
Intervention: Active second stage of labour > 60 min
Number of subjects: 6804

Group type: COMPARATOR
Intervention: Active second stage of labour ≤ 60 min
Number of subjects: 6804
Study: 32960155

Group type: EXPERIMENTAL
Intervention: SIT-WB (whole-body interval training)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: SIT-T (treadmill-based interval training)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: MICT (moderate-intensity continuous training)
Number of subjects: 41